This inventor holds 27 USPTO granted patents and 3 published patent applications and 9 EPO patents, primarily in Pharmaceutical Compounds. Top assignee: Eli Lilly and Company. Active years: 1998-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2022
Areas of Expertise:
Title: Cynthia Darshini Jesudason: Innovating in Diabetes Treatment
Introduction: Cynthia Darshini Jesudason, a talented inventor based in Indianapolis, IN, has made significant contributions to the field of pharmaceuticals with 27 patents under her name.
Latest Patents:
1. Triazolo Derivatives as PDE1 Inhibitors for the Treatment of Diabetes: Cynthia's invention provides a compound for use as a human PDE inhibitor, aimed at treating diabetes.
2. Azetidinyloxyphenylpyrrolidine Compounds: This invention offers methods of using compounds to treat overactive bladder, showing her diverse expertise in pharmaceuticals.
Career Highlights:
Cynthia Darshini Jesudason is associated with Eli Lilly and Company, a renowned pharmaceutical firm. Her innovative spirit and scientific prowess have led to pioneering inventions in the healthcare industry.
Collaborations:
Cynthia has collaborated with esteemed professionals at Eli Lilly and Company, including Freddie Craig Stevens and Don Richard Finley. Such collaborations have fueled her inventive journey and allowed for groundbreaking discoveries in pharmaceuticals.
Conclusion:
In conclusion, Cynthia Darshini Jesudason's remarkable work in inventing compounds for diabetes treatment and addressing overactive bladder showcases her dedication to advancing healthcare solutions. With a strong background in pharmaceuticals and ongoing collaborations, Cynthia continues to make a significant impact in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile